You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,654,844


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,654,844
Title:Dual mechanism inhibitors for the treatment of disease
Abstract: Provided are compounds that are inhibitors of both rho kinase and of a monoamine transporter (MAT) act to improve the disease state or condition. Further provided are compositions comprising the compounds. Further provided are methods for treating diseases or conditions, the methods comprising administering compounds according to the invention. One such disease may be glaucoma for which, among other beneficial effects, a marked reduction in intraocular pressure (IOP) may be achieved.
Inventor(s): deLong; Mitchell A. (Chapel Hill, NC), Sturdivant; Jill Marie (Chapel Hill, NC), Royalty; Susan M. (Davis, CA)
Assignee: Aerie Pharmaceuticals, Inc. (Bedminster, NJ)
Application Number:16/435,254
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,654,844: A Comprehensive Analysis

Introduction

Patent 10,654,844, like any other patent, is a complex document that outlines the scope, claims, and innovations of a particular invention. To analyze this patent, it is crucial to delve into its various components, including the background, summary, detailed description, and claims. Here, we will provide a detailed analysis of the patent landscape surrounding this specific patent, using general principles and guidelines from recent USPTO updates and patent search methodologies.

Background of the Patent

Patent Overview

United States Patent 10,654,844 is a utility patent that was granted to protect a specific invention. The background section of the patent typically provides context about the field of the invention, the problems it addresses, and any prior art that is relevant.

Importance of Background

The background section is essential for understanding the motivation behind the invention and how it differs from existing solutions. This section often includes a discussion of the current state of the art and any limitations or challenges in the field that the invention aims to overcome.

Summary of the Invention

Key Innovations

The summary section succinctly describes the main aspects of the invention. This includes the key innovations, the overall architecture or design, and how the invention operates. For Patent 10,654,844, this section would highlight what makes the invention unique and how it contributes to the field.

Role in Patent Landscape

The summary helps in placing the invention within the broader patent landscape. It provides a quick overview that can be used to compare the invention with other related patents and to identify potential areas of overlap or differentiation.

Detailed Description of the Invention

Technical Details

The detailed description section is where the patent delves into the technical specifics of the invention. This includes detailed drawings, diagrams, and a thorough explanation of how each component of the invention works. For Patent 10,654,844, this section would provide the necessary technical information to enable someone skilled in the art to replicate the invention.

Practical Applications

This section often includes examples of how the invention can be used in real-world scenarios. Demonstrating practical applications is crucial, as it helps in establishing the patent eligibility of the invention by showing how it integrates abstract ideas into concrete, practical uses[1].

Claims of the Patent

Claim Structure

The claims section is the most critical part of the patent, as it defines the scope of protection granted to the inventor. Claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Patent Eligibility

Recent USPTO guidance updates emphasize the importance of ensuring that claims integrate judicial exceptions into practical applications. For AI-related inventions, for example, the focus is on whether the claimed invention offers a concrete technological improvement and whether the abstract idea is applied in a way that provides clear benefits[1].

Examples from USPTO Guidance

The 2024 USPTO guidance provides examples that illustrate how claims can be crafted to meet patent eligibility criteria. For instance, Example 48 shows how specifying the use of separated audio components in a real-time speech recognition system can transform an abstract idea into a patent-eligible invention by providing a practical application that enhances the accuracy of voice commands[1].

Patent Scope and Breadth

Metrics for Measuring Scope

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. These metrics help in assessing the breadth and clarity of the patent claims. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Impact on Patent Landscape

The scope of Patent 10,654,844 would influence its position within the patent landscape. A patent with clear and narrowly defined claims is more likely to be granted and enforced effectively, while overly broad claims may face challenges during the examination process.

Search and Analysis Tools

USPTO Search Resources

To analyze the patent landscape surrounding Patent 10,654,844, one can use various search tools provided by the USPTO. The Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) are valuable resources for conducting thorough patent searches and analyzing prior art[4].

International Patent Databases

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can help in identifying similar inventions and assessing the global patent landscape[4].

Practical Implications and Real-World Applications

Demonstrating Practical Utility

To ensure patent eligibility, it is crucial to demonstrate how the invention provides practical utility and solves specific problems in the relevant field. This involves highlighting real-world applications and the tangible benefits of the invention[1].

Case Law and Recent Guidance

The incorporation of recent case law and USPTO guidance is essential for ensuring that the patent claims are drafted in a way that aligns with current legal standards. This helps in promoting consistency and clarity in the application of patent eligibility criteria[1].

Challenges and Considerations

Litigation and Licensing

The scope and claims of Patent 10,654,844 can impact its enforceability and the costs associated with litigation and licensing. Overly broad or unclear claims can lead to increased costs and diminished incentives for innovation[3].

Small Claims Patent Court

The concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could potentially affect the enforcement and litigation landscape for patents like 10,654,844. Such a court could provide a more streamlined and cost-effective process for resolving patent disputes[5].

Key Takeaways

  • Patent Eligibility: Ensure that claims integrate judicial exceptions into practical applications to meet patent eligibility criteria.
  • Practical Applications: Highlight real-world applications and tangible benefits of the invention.
  • Scope and Breadth: Use metrics like independent claim length and count to assess the breadth and clarity of patent claims.
  • Search and Analysis: Utilize USPTO and international patent databases to conduct thorough searches and analyze prior art.
  • Recent Guidance: Incorporate recent case law and USPTO guidance to align with current legal standards.

FAQs

What is the significance of the background section in a patent?

The background section provides context about the field of the invention, the problems it addresses, and relevant prior art, helping to understand the motivation and uniqueness of the invention.

How do recent USPTO guidance updates impact AI-related patent claims?

Recent updates emphasize evaluating whether claims integrate judicial exceptions into practical applications, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies and that significant human contribution is evident[1].

What metrics can be used to measure the scope of a patent?

Metrics such as independent claim length and independent claim count can be used to assess the breadth and clarity of patent claims[3].

Why is demonstrating practical utility important for patent eligibility?

Demonstrating practical utility helps in establishing that the invention provides concrete benefits and solves specific problems in the relevant field, which is crucial for meeting patent eligibility criteria[1].

How can international patent databases aid in patent analysis?

International patent databases help in identifying similar inventions globally, assessing the global patent landscape, and ensuring that the invention is novel and non-obvious on a global scale[4].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent: Mintz, 2024.
  2. U.S. Patent and Trademark Office (USPTO) | USAGov: USA.gov.
  3. Patent Claims and Patent Scope: SSRN, 2016.
  4. Search for patents - USPTO: USPTO.
  5. U.S. Patent Small Claims Court: ACUS.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,654,844

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alcon Labs Inc RHOPRESSA netarsudil mesylate SOLUTION/DROPS;OPHTHALMIC 208254-001 Dec 18, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y Y REDUCTION OF ELEVATED INTRAOCULAR PRESSURE ⤷  Subscribe
Alcon Labs Inc ROCKLATAN latanoprost; netarsudil dimesylate SOLUTION/DROPS;OPHTHALMIC 208259-001 Mar 12, 2019 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y Y REDUCTION OF ELEVATED INTRAOCULAR PRESSURE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,654,844

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3053913 ⤷  Subscribe 301038 Netherlands ⤷  Subscribe
European Patent Office 3053913 ⤷  Subscribe 122020000016 Germany ⤷  Subscribe
European Patent Office 3053913 ⤷  Subscribe 2020C/510 Belgium ⤷  Subscribe
European Patent Office 3053913 ⤷  Subscribe 132020000000043 Italy ⤷  Subscribe
European Patent Office 3053913 ⤷  Subscribe 2020/016 Ireland ⤷  Subscribe
European Patent Office 3053913 ⤷  Subscribe C202030018 Spain ⤷  Subscribe
European Patent Office 3053913 ⤷  Subscribe 20C1017 France ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.